MalarVx Analysis: $2M Raised
What is MalarVx?
A malaria vaccine company with a new approach
HQ Country
Seattle, United States
Employees
1-10
Founded
2012
HQ State/Province
Washington
Funding Category
Not Funded
HQ Full Address
307 Westlake Ave N, Seattle, Washington 98109, United States
Product Features & Capabilities
- Vaccine development
- In vitro mosquito-stages research
- Clinical trials pipeline
- Scientific publications
